
Near-term beat unlikely as gov budget shifts, BH renegotiation, and thin sales coverage weigh; CSP1 ramp key.
Disclaimer: The content provided in this newsletter is for informational purposes only and does not constitute investment advice. We are not registered investment advisors, and nothing in this newsletter should be construed as a recommendation to buy or sell any securities. Always do your own research and consult with a licensed financial professional before making any investment decisions.
In our previous research note, we highlighted several key issues to watch this quarter: BH’s renewal status, progress in CSP-related business expansion, the conversion of prior trials and demo revenues into paid engagements, and potential management changes. Ideally, we were looking for this earnings call to provide clarity on these issues before deciding whether to take a position. Based on current indications, delivering a revenue beat without relying heavily on trial/demo revenues or service fees still appears challenging.
We continuously track C3.AI's quarterly performance; previous reports are available.
Q4 YoY revenue: –10% or more; many teams missed their quarterly target by ~5%
In contrast, last quarter saw ~+10% YoY growth, with multiple groups exceeding sales quotas
This report is available to subscribers. Sign in or subscribe to read the full analysis.